Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 132, Issue 2, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI153357
Keywords
-
Categories
Funding
- NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK063491, R01DK117551, R01DK076906, R00HL143277, 1 F32 DK124947-01A1, T32 DK007044]
- NIH [DK058037, DK101573, DK102948, DK066369, R01 DK117850, R01 HL147883]
- University of Wisconsin-Madison, Department of Biochemistry
- University of Wisconsin-Madison, Office of the Vice Chancellor for Research and Graduate Education
- Wisconsin Alumni Research Foundation
- Swedish Research Council
- ERC-SyG SPHERES [856404]
- NovoNordisk Foundation (Tripartite Immunometabolism Consortium) [NNF15CC0018486]
- MSAM consortium [NNF-15SA0018346]
- MeRIAD consortium [0064142]
- Knut and Alice Wallenbergs Foundation
- CIMED
- Swedish Diabetes Foundation
- Stockholm County Council
- Strategic Research Program in Diabetes at Karolinska Institutet
- European Research Council (ERC) [856404] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
This study investigates the resistance of multiple hormones in obesity and reveals that catecholamine resistance and elevated inflammation lead to the downregulation of beta 3-adrenergic receptor expression. The study also demonstrates that the induction of the pseudokinase TRIB1, downstream of the EPAC/RAP2A/PI-PLC pathway, triggers both homologous and heterologous desensitization of the Adrb3 receptor, inhibiting lipolysis and energy expenditure.
The dysregulation of energy homeostasis in obesity involves multihormone resistance. Although leptin and insulin resistance have been well characterized, catecholamine resistance remains largely unexplored. Murine beta 3-adrenergic receptor expression in adipocytes is orders of magnitude higher compared with that of other isoforms. While resistant to classical desensitization pathways, its mRNA (Adrb3) and protein expression are dramatically downregulated after ligand exposure (homologous desensitization). beta 3-Adrenergic receptor downregulation also occurs after high-fat diet feeding, concurrent with catecholamine resistance and elevated inflammation. This downregulation is recapitulated in vitro by TNF alpha treatment (heterologous desensitization). Both homologous and heterologous desensitization of Adrb3 were triggered by induction of the pseudokinase TRIB1 downstream of the EPAC/RAP2A/PI-PLC pathway. TRIB1 in turn degraded the primary transcriptional activator of Adrb3, CEBP alpha. EPAC/RAP inhibition enhanced catecholamine-stimulated lipolysis and energy expenditure in obese mice. Moreover, adipose tissue expression of genes in this pathway correlated with body weight extremes in a cohort of genetically diverse mice and with BMI in 2 independent cohorts of humans. These data implicate a signaling axis that may explain reduced hormone-stimulated lipolysis in obesity and resistance to therapeutic interventions with beta 3-adrenergic receptor agonists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available